SENTINEL NODE BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, Request sample copy

Regional Analysis:

Dominating Region: North America

North America dominates the global sentinel node biopsy industry with an estimated share of 38.2% in 2024. This is driven by factors such as a strong presence of leading pharmaceutical and medical device companies, availability of advanced healthcare infrastructure, and favorable government policies that encourage innovations and research activities in the region.

Fastest-Growing Region: Asia Pacific

The Asia Pacific market exhibits the fastest growth in the sentinel node biopsy industry due to rising healthcare expenditure, growing medical tourism industry, increasing cases of cancer, and rising awareness about disease diagnosis and treatment.

Sentinel Node Biopsy Market Outlook for Key Countries

Advancements in Medical Technology Fuel Sentinel Node Biopsy Growth in the U.S.

The U.S. sentinel node biopsy market benefits from the widespread adoption of cutting-edge medical technologies, which enhance the accuracy and efficiency of sentinel node biopsy procedures. For example, in April 2022, KUBTEC Medical Imaging, a medical technology company, launched its wireless sentinel lymph node localization technology at the 23rd annual meeting of the American Society of Breast Surgeons, highlighting the continuous innovation in the field. The introduction of advanced imaging technologies is expected to further boost the demand for sentinel node biopsies in the country.

Rising Cancer Cases and Technological Advancements Drive Market Expansion in Japan

Japan sentinel node biopsy industry is expected to experience growth during the forecast period, driven by factors such as an increasing number of cancer cases and ongoing advancements in technology. For example, in September 2023, the National Cancer Center of Japan reported around 1,019,000 new cancer diagnoses and 380,400 cancer-related deaths in 2022.

Increased Awareness and Healthcare Spending Boost Sentinel Node Biopsy Market Growth in France

France sentinel node biopsy industry is projected to grow during the forecast period, fueled by increasing awareness about cancer treatments and rising healthcare expenditure. For instance, data from the Institut Montaigne published in January 2022 indicates that France allocates over 11% of its GDP to healthcare.

High Adoption of Advanced Surgical Technologies Supports Market Growth in Germany

Germany sentinel node biopsy industry is supported by high adoption rates of advanced surgical technologies. The German Cancer Society reported in February 2023 that 80% of breast cancer patients receive sentinel node biopsy to assess cancer spread. In December 2022, the German Federal Ministry of Health approved new reimbursement guidelines to support the use of advanced imaging techniques in sentinel node biopsy.